Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion
Authors:
- Mizuko TanakaMTMizuko Tanaka
- Naoki Ichikawa-TomikawaNINaoki Ichikawa-Tomikawa
- Namiko ShishitoNSNamiko Shishito
- Keisuke NishiuraKNKeisuke Nishiura
- Tomiko MiuraTMTomiko Miura
- Ayumi HozumiAHAyumi Hozumi
- Hideki ChibaHideki Chiba
- Sayaka YoshidaSYSayaka Yoshida
- Tohru OhtakeTOTohru Ohtake
- Takashi SuginoTSTakashi Sugino
Open Access
- 13 February 2015
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 15 (1) , 1-14
Abstract
S100 family proteins have recently been identified as biomarkers in various cancers. Of this protein family, S100A14 and S100A16 are also believed to play an important role in tumor progression. The aim of the present study was to clarify the clinical significance and functional role of these molecules in breast cancer. In a clinical study, an immunohistochemical analysis of S100A14 and S100A16 expression in archival specimens of primary tumors of 167 breast cancer patients was performed. The relationship of S100A14 and S100A16 expression to patient survival and clinicopathological variables was statistically analyzed. In an experimental study, the subcellular localization and function of these molecules was examined by using the human breast cancer cell lines MCF7 and SK-BR-3, both of which highly express S100A14 and S100A16 proteins. Cells transfected with expression vectors and siRNA for these genes were characterized using in vitro assays for cancer invasion and metastasis. Immunohistochemical analysis of 167 breast cancer cases showed strong cell membrane staining of S100A14 (53% of cases) and S100A16 (31% of cases) with a significant number of cases with co-expression (p < 0.001). Higher expression levels of these proteins were significantly associated with a younger age (<60 years), ER-negative status, HER2-positive status and a poorer prognosis. Co-expression of the two proteins showed more aggressive features with poorer prognosis. In the human breast cancer cell lines MCF7 and SK-BR-3, both proteins were colocalized on the cell membrane mainly at cell-cell attachment sites. Immunoprecipitation and immunofluorescence analyses demonstrated that the 100A14 protein can bind to actin localized on the cell membrane in a calcium-independent manner. A Boyden chamber assay showed that S100A14 and S100A16 knockdown substantially suppressed the invasive activity of both cell lines. Cell motility was also inhibited by S100A14 knockdown in a modified dual color wound-healing assay. To our knowledge, this is the first report showing the correlation of expression of S100A14, S100A16, and co-expression of these proteins with poor prognosis of breast cancer patients. In addition, our findings indicate that S100A14 and S100A16 can promote invasive activity of breast cancer cells via an interaction with cytoskeletal dynamics. S100A14 and S100A16 might be prognostic biomarkers and potential therapeutic targets for breast cancer.Keywords
This publication has 28 references indexed in Scilit:
- Downregulation of 425G>A variant of calcium-binding protein S100A14 associated with poor differentiation and prognosis in gastric cancerJournal of Cancer Research and Clinical Oncology, 2014
- S100A14, a Member of the EF-hand Calcium-binding Proteins, Is Overexpressed in Breast Cancer and Acts as a Modulator of HER2 SignalingJournal of Biological Chemistry, 2014
- Calcium-dependent and -independent interactions of the S100 protein familyBiochemical Journal, 2006
- Annexin A2 heterotetramer: role in tight junction assemblyAmerican Journal of Physiology-Renal Physiology, 2004
- Differential expression of S100 gene family in human esophageal squamous cell carcinomaJournal of Cancer Research and Clinical Oncology, 2004
- S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumorsBiochemical and Biophysical Research Communications, 2004
- AHNAK interaction with the annexin 2/S100A10 complex regulates cell membrane cytoarchitectureJournal of Cell Biology, 2003
- An Invasion-Independent Pathway of Blood-Borne MetastasisThe American Journal of Pathology, 2002
- Molecular Cloning and Characterization of the Human S100A14 Gene Encoding a Novel Member of the S100 FamilyGenomics, 2002
- Calcium-dependent translocation of S100A11 requires tubulin filamentsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000